MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) at Dr. Essa Lab

Overview of MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) at Dr. Essa Lab

The MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) is a highly specialized, state-of-the-art neuroimaging examination performed at Dr. Essa Lab. This diagnostic scan is specifically designed to evaluate the brain parenchyma with a dedicated, high-resolution focus on the Internal Auditory Meatus (IAM), also known as the internal acoustic canal. The IAM is a bony canal within the temporal bone that houses vital cranial nerves, including the facial nerve (Cranial Nerve VII) and the vestibulocochlear nerve (Cranial Nerve VIII), along with the labyrinthine artery. By utilizing advanced Magnetic Resonance Imaging (MRI) technology, this protocol provides exceptionally detailed, thin-slice cross-sectional images of these delicate anatomical structures, the cerebellopontine angle (CPA) cisterns, and the inner ear structures (cochlea, vestibule, and semicircular canals).

This examination is performed both with and without intravenous (IV) contrast. The pre-contrast (plain) phase utilizes advanced sequences such as high-resolution 3D T2-weighted imaging (often referred to as CISS, FIESTA, or constructive interference in steady state) to outline the cranial nerves within the cerebrospinal fluid (CSF) spaces with exquisite anatomical precision. The post-contrast phase involves the administration of a gadolinium-based contrast agent. Contrast enhancement is clinically indispensable because it dramatically improves the sensitivity and specificity of the scan. It allows neuroradiologists to detect micro-lesions, such as tiny vestibular schwannomas (acoustic neuromas) measuring only a few millimeters, which might otherwise be invisible on non-contrast sequences. The contrast agent highlights areas of increased vascularity or blood-brain barrier disruption, helping to differentiate between neoplastic, inflammatory, infectious, and vascular pathologies.

At Dr. Essa Lab, this protocol is executed using advanced high-field MRI systems and dedicated head coils. This technological setup ensures an optimal signal-to-noise ratio, allowing for sub-millimeter slice thickness and superior spatial resolution. This examination is of paramount clinical importance for patients presenting with unexplained hearing loss, persistent tinnitus, vertigo, or facial nerve symptoms. It serves as the gold standard diagnostic tool, guiding neurologists, otolaryngologists (ENT specialists), and neurosurgeons in formulating precise, evidence-based treatment plans.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure patient safety and obtain the highest quality diagnostic images. Because this procedure involves both non-contrast and contrast-enhanced imaging, patients must adhere to the following guidelines:

• Fasting Requirements: Patients are generally advised to fast (nothing by mouth) for 4 to 6 hours prior to the scheduled scan. This precaution helps minimize the risk of mild nausea or vomiting, which can occasionally occur during or immediately after the administration of the intravenous gadolinium contrast agent.
• Renal Function Testing: Since the examination requires the injection of a gadolinium-based contrast medium, patients must provide a recent Serum Creatinine and estimated Glomerular Filtration Rate (eGFR) report (usually within the last 30 to 45 days). This is crucial to ensure that the kidneys are functioning adequately to filter and excrete the contrast agent safely.
• Safety Screening and Metal Removal: MRI utilizes an extremely powerful magnetic field. Patients must complete a comprehensive safety screening questionnaire to identify any internal metallic implants, such as cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), cochlear implants, metallic vascular clips, or retained foreign bodies. All external metallic objects, including jewelry, watches, hairpins, hearing aids, eyeglasses, and clothing with metallic zippers or buttons, must be removed before entering the MRI suite.
• Medical History and Allergies: Patients must inform the clinical staff at Dr. Essa Lab of any known allergies, particularly previous adverse reactions to contrast media, as well as any history of asthma, severe renal disease, or pregnancy.

During the Procedure

The scanning process is conducted by highly trained MRI technologists and monitored by consultant radiologists. The procedure follows a structured sequence to ensure patient comfort and diagnostic accuracy:

• Patient Positioning: The patient is positioned comfortably in a supine position (lying flat on their back) on the motorized MRI table. A specialized head coil, which acts as an antenna to transmit and receive radiofrequency signals, is placed over the patient’s head. Comfortable padding is used to secure the head and minimize voluntary or involuntary movement, which can cause image-blurring artifacts.
• Intravenous Access: A peripheral intravenous (IV) catheter is inserted into a vein, typically in the arm or hand, before the scan begins. This line is used to administer the gadolinium contrast agent mid-way through the examination.
• The Scanning Process: The MRI table slides slowly into the cylindrical bore of the scanner. The scanner is well-lit and ventilated. During the scan, the machine produces loud, rhythmic tapping, thumping, and buzzing noises as the gradient coils switch on and off. To protect the patient’s hearing, comfortable earplugs or noise-canceling headphones are provided. The patient can communicate with the technologist at any time via an intercom system and a handheld emergency squeeze bulb.
• Contrast Administration: After the initial non-contrast sequences (including high-resolution 3D T2-weighted sequences of the IAM) are completed, the gadolinium contrast agent is injected through the IV line. The patient may experience a brief, transient cold sensation in the arm during the injection, which is entirely normal. Post-contrast T1-weighted sequences are then acquired in multiple planes.
• Duration and Safety: The entire procedure typically takes between 45 and 60 minutes. The patient must remain absolutely still throughout this period. The scan is completely painless, non-invasive, and does not utilize ionizing radiation, making it exceptionally safe when proper screening protocols are followed.

When is a MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) Performed?

Unilateral Sensorineural Hearing Loss (SNHL)

Unilateral sensorineural hearing loss, or a significant asymmetry in hearing thresholds between the two ears, is one of the primary clinical indications for this specialized MRI protocol. Unlike conductive hearing loss, which involves the outer or middle ear, sensorineural hearing loss originates from pathology within the cochlea or along the pathway of the vestibulocochlear nerve (CN VIII) to the brainstem. Physicians request this scan to rule out retrocochlear pathologies, most notably vestibular schwannomas (acoustic neuromas). By utilizing thin-slice, high-resolution imaging with contrast, the scan can detect even microscopic intracanalicular tumors that compress the nerve fibers, allowing for early diagnosis and preservation of residual hearing or facial nerve function.

Persistent Tinnitus (Ringing in the Ears)

Tinnitus, characterized by the perception of noise or ringing in the ears without an external source, can be highly debilitating. When tinnitus is unilateral, persistent, or pulsatile, it warrants a detailed radiological evaluation. Unilateral non-pulsatile tinnitus is frequently the first symptom of a cerebellopontine angle (CPA) lesion or a tumor within the internal auditory canal. This MRI protocol helps clinicians determine if the tinnitus is caused by a structural lesion, such as a schwannoma, meningioma, or epidermoid cyst, or if there is an underlying vascular anomaly, such as a vascular loop compressing the vestibulocochlear nerve within the CPA cistern.

Vertigo, Dizziness, and Balance Disorders

The vestibular branch of the eighth cranial nerve is responsible for transmitting balance and spatial orientation information from the semicircular canals to the brain. Chronic, unexplained vertigo, progressive imbalance, or episodic dizziness can indicate pathology affecting this vestibular pathway. This MRI protocol is highly effective in evaluating the vestibular nerve, the vestibular nuclei within the brainstem, and the cerebellum. It assists physicians in differentiating peripheral vestibular disorders (such as labyrinthitis or vestibular neuritis, which show characteristic contrast enhancement) from central vestibular disorders, including brainstem strokes, demyelinating plaques, or cerebellar tumors.

Facial Nerve Dysfunction or Hemifacial Spasm

The facial nerve (Cranial Nerve VII) runs alongside the vestibulocochlear nerve within the narrow confines of the internal auditory meatus. Pathological processes affecting this canal can compress or irritate the facial nerve, leading to facial weakness, paralysis (resembling Bell’s palsy), or involuntary twitching (hemifacial spasm). This MRI protocol is requested to evaluate the entire course of the facial nerve, from its origin in the brainstem, through the CPA cistern, the IAM, the fallopian canal, and its exit at the stylomastoid foramen. The use of IV contrast is critical here, as it can reveal perineural tumor spread, facial nerve neuromas, or localized inflammatory changes associated with atypical facial palsies.

Evaluation of Cerebellopontine Angle (CPA) Masses

The cerebellopontine angle is a CSF-filled space in the posterior cranial fossa that is highly prone to various extra-axial tumors. When a patient presents with a combination of cranial nerve deficits, headaches, or cerebellar signs (such as ataxia), a CPA mass is suspected. This MRI protocol is the definitive imaging modality to characterize CPA lesions. It allows radiologists to differentiate between the three most common CPA masses: vestibular schwannomas (which typically show intense, uniform contrast enhancement and widen the IAM), meningiomas (which often exhibit a dural tail sign and are eccentric to the IAM), and epidermoid cysts (which show characteristic restricted diffusion on DWI sequences and do not enhance with contrast).

What Does a MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) Detect?

This comprehensive neuroimaging protocol is capable of detecting a wide spectrum of neoplastic, inflammatory, vascular, and congenital abnormalities. Specific findings include:

• Vestibular Schwannoma (Acoustic Neuroma): A benign, slow-growing tumor originating from the Schwann cells of the vestibulocochlear nerve, showing intense contrast enhancement.
• Cerebellopontine Angle Meningioma: A benign extra-axial tumor arising from the arachnoid cap cells, characterized by broad-based dural attachment and uniform contrast enhancement.
• Epidermoid Cyst: A congenital lesion in the CPA cistern that appears similar to CSF on T1 and T2 sequences but shows characteristic hyperintensity on Diffusion-Weighted Imaging (DWI).
• Arachnoid Cyst: A benign, fluid-filled sac within the CPA cistern that follows CSF signal intensity on all sequences and does not restrict diffusion or enhance.
• Facial Nerve Schwannoma: A rare tumor of the seventh cranial nerve that can cause progressive facial palsy and enhances intensely with gadolinium.
• Vascular Loop Compression: An anatomical variant where a loop of the anterior inferior cerebellar artery (AICA) or superior cerebellar artery (SCA) directly contacts and compresses the cisternal segment of CN VII or CN VIII, often associated with hemifacial spasm or trigeminal neuralgia.
• Labyrinthitis: Acute or chronic inflammation of the membranous labyrinth of the inner ear, demonstrating abnormal enhancement of the cochlea and vestibule on post-contrast images.
• Vestibular Neuritis: Inflammation of the vestibular nerve, characterized by isolated enhancement of the nerve within the internal auditory canal.
• Petrous Apicitis: Infection and inflammation of the petrous apex of the temporal bone, often associated with Gradenigo’s syndrome.
• Cholesterol Granuloma: A benign, expansile lesion of the petrous apex that typically shows high signal intensity on both T1 and T2-weighted images due to cholesterol crystals and hemorrhage.
• Demyelinating Plaques (Multiple Sclerosis): Areas of demyelination within the brainstem, cerebellar peduncles, or cerebral hemispheres, which may show active enhancement if acutely inflamed.
• Brainstem Glioma: A primary neoplasm of the brainstem that alters normal signal intensity and may show variable contrast enhancement.
• Cerebellar Infarction: Ischemic stroke within the cerebellar hemispheres or brainstem, characterized by restricted diffusion on DWI.
• Vertebrobasilar Dolichoectasia: Elongation, widening, and tortuosity of the basilar or vertebral arteries, which can compress adjacent cranial nerves or the brainstem.
• Otosclerosis: A metabolic bone disease of the otic capsule; active phases (otospongiosis) can show localized enhancement around the cochlea.
• Labyrinthine Ossification: Pathological bone deposition within the fluid spaces of the inner ear, visible as a loss of normal fluid signal on high-resolution T2-weighted sequences.
• Endolymphatic Sac Tumor: A rare, locally aggressive vascular tumor of the temporal bone, often associated with Von Hippel-Lindau disease.
• Metastatic Disease: Secondary malignant deposits within the temporal bone, CPA, or brain parenchyma, showing nodular or ring-like contrast enhancement.
• Leptomeningeal Carcinomatosis: Diffuse infiltration of tumor cells throughout the subarachnoid space, visible as thin, sheet-like enhancement along the brain surface and cranial nerves.
• Bell’s Palsy (Atypical): Enhancement of the intratemporal segments of the facial nerve, helping to confirm inflammatory facial neuropathy.
• Neurosarcoidosis: Granulomatous inflammation that can affect the cranial nerves and meninges, showing nodular contrast enhancement.
• Cerebellar Hemangioblastoma: A highly vascular, benign tumor of the cerebellum, often presenting as a cyst with an intensely enhancing mural nodule.
• Chiari Malformation: Congenital herniation of the cerebellar tonsils through the foramen magnum, which can alter CSF flow dynamics.
• Normal Brain Parenchyma: Confirmation of healthy cerebral, cerebellar, and brainstem structures without signal abnormalities.
• Normal Ventricular System: Verification of normal-sized ventricles, ruling out obstructive hydrocephalus secondary to a posterior fossa mass.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. Once your MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) is completed, the extensive dataset of high-resolution images is transferred to our advanced Picture Archiving and Communication System (PACS). A highly qualified consultant radiologist, specializing in neuroradiology, meticulously reviews and interprets the pre-contrast and post-contrast scans, comparing them with any provided clinical history or previous imaging studies.

The finalized, medically verified diagnostic report is typically compiled and made available within 24 to 48 hours of the scan. Dr. Essa Lab offers a highly convenient digital reporting service. Patients and their referring physicians can easily access, view, and download the diagnostic reports and high-quality imaging files online through the official Dr. Essa Lab web portal or dedicated mobile application. Physical copies of the report and imaging films or CDs can also be collected directly from the diagnostic center where the scan was performed.

MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Cerebellopontine Angle (CPA) Cisterns	Symmetric, CSF-filled spaces; free of extra-axial masses or abnormal tissue.	Extra-axial masses (schwannoma, meningioma, epidermoid cyst); narrowing of the cistern.
Internal Auditory Canals (IAC)	Symmetric caliber and width; no bony erosion or expansion.	Widening or erosion of the canal; presence of an intracanalicular soft tissue mass.
Cranial Nerve VII (Facial Nerve)	Normal course, symmetric caliber, no abnormal nodular enhancement.	Thickening, nodular enhancement, or displacement by an adjacent mass (e.g., facial schwannoma).
Cranial Nerve VIII (Vestibulocochlear)	Intact, symmetric, normal signal intensity, no focal enhancement.	Focal, intensely enhancing mass (vestibular schwannoma); diffuse enhancement (neuritis).
Inner Ear (Cochlea & Vestibule)	Normal fluid signal on T2; no abnormal post-contrast enhancement.	Loss of fluid signal (ossification); abnormal enhancement (labyrinthitis).
Brainstem and Cerebellum	Normal signal intensity, symmetric structures, no focal lesions or mass effect.	Demyelinating plaques (MS), ischemic infarcts, gliomas, or cerebellar atrophy.
Ventricular System	Normal size and configuration; symmetric ventricles; no obstruction.	Ventriculomegaly; obstructive hydrocephalus due to a large posterior fossa mass.
Cerebral Parenchyma	Normal gray-white matter differentiation; no acute ischemia or hemorrhage.	Microvascular ischemic changes, demyelinating lesions, or metastatic disease.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for MRI BRAIN (WITH IAM PROTOCOL) WITH AND WITHOUT IV CONTRAST (DELDC)?

• Experienced Healthcare Professionals: Our team consists of highly qualified, board-certified consultant radiologists and skilled MRI technologists specializing in advanced neuroimaging.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the entire diagnostic imaging process.
• Quality Diagnostic Services: Dr. Essa Lab is committed to maintaining the highest standards of diagnostic accuracy, utilizing rigorous quality control protocols.
• Professional Reporting: We provide detailed, comprehensive, and clinically precise diagnostic reports designed to guide effective treatment planning.
• Modern Diagnostic Approach: Our facilities utilize advanced high-field MRI systems and specialized protocols to ensure exceptional image resolution.
• Comfortable Environment: We offer a clean, welcoming, and patient-friendly environment designed to minimize anxiety, particularly for claustrophobic patients.
• Convenient Location: With multiple accessible branches across Karachi and other major cities, patients can easily access our premium diagnostic services.
• Commitment to Accurate Diagnosis: As a pioneer in the diagnostic sector of Pakistan, Dr. Essa Lab has built decades of trust through reliable and timely medical reporting.